Skip to main content
Clinical Trials/CTRI/2014/06/004660
CTRI/2014/06/004660
Completed
未知

A Prospective, open labeled, clinical study to evaluate the efficacy and safety of DENPAP of liquid syrup in the treatment of Dengue fever

GOAN Pharma P Ltd0 sites15 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
GOAN Pharma P Ltd
Enrollment
15
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 27, 2014
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
GOAN Pharma P Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Males and females of age group 18\-60 years
  • 2\.Subjects with low platelet count(\>\=70,000\) and IgG or IgM or both antibodies positive cases only
  • 3\.Subjects who are willing to give written informed consent along with audio, video recording
  • 4\.Patient is willing and able to comply with all trial requirements

Exclusion Criteria

  • 1\.Patients with adequate platelet count and IgG and IgM antibodies negative
  • 2\.Subjects had bleeding manifestations or mixed infections (tested positive for malaria, leptospirosis along with dengue) or a recent ( \<120 days) transfusion of plate\-lets \& whole blood
  • 3\.Have a history of Angina, stroke, thyroid diseases
  • 4\.Present history of mental diseases
  • 5\.Previous participation in a clinical trial within 6 months.
  • 6\.Pregnant or lactating woman

Outcomes

Primary Outcomes

Not specified

Similar Trials